SREBF1 and metabolic dysfunction-associated steatotic liver disease: Several studies have shown that osthole can treat NAFLD by upregulating PPAR-α and downregulating liver proteins like NF-κB, SREBP1c, and FAS, which ultimately reduces liver steatosis and inflammation [144,163].